三個皮匠報告
政策庫
new
付費
搜索

預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元-行業數據

預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元
批；二/三線治療 EGFR TKI 耐藥非小細胞肺癌有望于 2025 年在美國獲批；二/三線治療 EGFR TKI耐藥非小細胞肺癌有望于 2026年在中國獲批；
其它 下載Excel 下載圖片 原圖定位
圖片屬性
圖片格式：PNG 圖片大?。?59KB 圖片尺寸：2327*410
同報告圖片
 / 64
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第1頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第2頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第3頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第4頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第5頁
fCDnmYznl4fnsbvlnosgfCDmlbDph48gICAgIHwg55m+5YiG5q+UICAgfAp8IC0tLS0tLS0tIHwgLS0tLS0tLS0gfCAtLS0tLS0tLSB8Cnwg6IK655mMICAgICB8IDgxNSw1NjMgIHwgMTcuOSUgICAgfAp8IOe7k+ebtOiCoOeZjCB8IDU1NSw0NzcgIHwgMTIuMiUgICAgfAp8IOiDg+eZjCAgICAgfCA0NzgsNTA4ICB8IDEwLjUlICAgIHwKfCDkubPohbrnmYwgICB8IDQxNiwzNzEgIHwgOS4xJSAgICAgfAp8IOiCneeZjCAgICAgfCA0MTAsMDM4ICB8IDklICAgICAgIHwKfCDpo5/nrqHnmYwgICB8IDMyNCw0MjIgIHwgNy4xJSAgICAgfAp8IOeUsueKtuiFuueZjCB8IDIyMSwwOTMgIHwgNC44JSAgICAgfAp8IOWFtuS7lueZjOeXhyB8IDEsMzQ3LDI4MiB8IDI5LjUlICAgIHwKCui1hOaWmeadpea6kO+8mkdMT0JPQ0FOIDIwMjA=
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第6頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第7頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第8頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第9頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第10頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第11頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第12頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第13頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第14頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第15頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第16頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第17頁
fCDmnJ/pl7QgfCDopIflkIjlubTlop7plbfnjocgfCDph5Hpop3vvIjljYHlhITnvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCAyMDE25bm06IezMjAyMOW5tCB8IDUuNyUgICAgICAgfCA0LjMgICAgICAgICAgfAp8IDIwMjDlubToh7MyMDI15bm077yI5Lyw6KiI77yJIHwgMTQuNSUgICAgICB8IDYuMCAgICAgICAgICB8CnwgMjAyNeW5tO+8iOS8sOioiO+8ieiHszIwMzDlubTvvIjkvLDoqIjvvIkgfCAxMi44JSAgICAgIHwgMjEuNSAgICAgICAgIHw=
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第18頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第19頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第20頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第21頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第22頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第23頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第24頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第25頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第26頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第27頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第28頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第29頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第30頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第31頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第32頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第33頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第34頁
fCDlubTku70gfCDlronnvZfmm7/lsLzplIDllK7pop3vvIjkur/lhYPvvIkgfCDmlLblhaXlop7pgJ8gfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAyMCB8IDQwICAgICAgICAgICAgICAgICAgICAgICB8IDQ2LjUwJSAgIHwKfCAyMDIxIHwgMzkgICAgICAgICAgICAgICAgICAgICAgIHwgLTMuODAlICAgfAp8IDIwMjIgfCA0MSAgICAgICAgICAgICAgICAgICAgICAgfCA0LjY1JSAgICB8CnwgMjAyMyAoUTEtUTMpIHwgMzAgICAgICAgICAgICAgICAgICAgICB8ICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQuOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第35頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第36頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第37頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第38頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第39頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第40頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第41頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第42頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第43頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第44頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第45頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第46頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第47頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第48頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第49頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第50頁
fCDljp/lj5Hngbbpg6jkvY0gfCDliIblsYIgfCBJ57qn5o6o6I2QIHwgSUnnuqfmjqjojZAgfCBJSUnnuqfmjqjojZAgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IOw6IW6IHwgRzEvRzIgfCBTU0EgKElB57G7KeS+nee7tOiOq+WPuCAoSUHnsbsp57Si5Yeh5pu/5bC8IChJQeexuynoiJLlsLzmm7/lsLwgKElB57G7KUNBUFRFTSAoMkHnsbspIHwgUFJSVCAoMkHnsbsp6ZO+6ISy6ZyJ57Sg5Li65Z+656GA55qE5YyW55aX5pa55qGIICgyQeexuykgfCDovr7ljaHlt7Tll6rCseawn+Wwv+WYp+WVtiAoMkLnsbsp6KeC5a+fIHwKfCDog7DohbogfCBHMyB8IOS4tOW6iueglOeptiB8IENBUFRFTSAoMkHnsbspIHwg6IiS5bC85pu/5bC8ICgz57G7KeS+nee7tOiOq+WPuCAoM+exuylGT0xFT3ggKDJC57G7KemTvuiEsumciee0oOS4uuWfuuehgOeahOaWueahiCAoMkLnsbspUFJSVCAoM+exuylTU0EgKDPnsbspIHwKfCDog4PogqDpgZMgfCBHMS9HMiB8IFNTQSAoSUHnsbsp57Si5Yeh5pu/5bC8IChJQeexuynkvp3nu7Tojqvlj7ggKElB57G7KSB8IFBSUlQgKElB57G7KSB8IOinguWvn+WMlueWlyAoM+exuykgfAp8IOiDg+iCoOmBkyB8IEczIHwg5Li05bqK56CU56m2IHwgLSB8IOWMlueWlyAoM+exuylQUlJUICgz57G7KVNTQSAoM+exuykgfAp8IOiCuuaIluiDuOiFuiB8IOWFuOWei+exu+eZjC/pnZ7lhbjlnovnsbvnmYwgfCDntKLlh6Hmm7/lsLwgKElB57G7KeS+nee7tOiOq+WPuCAoSUHnsbspU1NBICgyQeexuykgfCDljJbnlpcgKDJC57G7KVBSUlQgKDJC57G7KSB8IOinguWvnyB8CgoK6LWE5paZ5p2l5rqQ77yaMjAyMUNTQ0/or4rnlpfmjIfljZfjgIHlvIDmupDor4HliLjnoJTnqbbmiYA=
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第51頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第52頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第53頁
fCAgfCAyMDIx5bm0UTMgfCAyMDIy5bm0UTEgfCAyMDIy5bm0UTMgfCAyMDIz5bm0UTEgfCAyMDIz5bm0UTQgfAp8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8IC0tLSB8Cnwg6IuP5rOw6L6+IHwgNyUgfCAxNCUgfCAxNiUgfCAxNyUgfCAyMSUgfAp8IOeUn+mVv+aKkee0oOexu+S8vOeJqSB8IDUzJSB8IDQ3JSB8IDQyJSB8IDM2JSB8IDM4JSB8Cnwg57Si5Z2mIHwgMTQlIHwgMTQlIHwgMTQlIHwgMTMlIHwgMTAlIHwKfCDpo57lsLzlpqUgfCAxMCUgfCA5JSB8IDEwJSB8IDExJSB8IDklIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOaKleWFs+adkOaWmeOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第54頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第55頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第56頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第57頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第58頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第59頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第60頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第61頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第62頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第63頁
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
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第64頁
預計索凡替尼治療神經內分泌腫瘤患者中國銷售峰值近8億元_第65頁
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
所屬報告： 和黃醫藥-港股公司首次覆蓋報告：深度聚焦腫瘤小分子賽道進入全球市場收獲期-240613（40頁）.pdf
打包全文圖表

相關數據

最新數據
聯系我們
  • 0731-84720580
  • sgpjbg002
  • 工作日 9:30 - 18:00
關于我們
侵權處理
關于我們

三個皮匠報告專業的行業報告下載站，每日更新，歡迎大家關注！

copyright@2008-2013 長沙景略智創信息技術有限公司版權所有
網站備案/許可證號：湘B2-20190120

客服
商務合作
小程序
服務號
折疊
午夜网日韩中文字幕,日韩Av中文字幕久久,亚洲中文字幕在线一区二区,最新中文字幕在线视频网站